GEOVAX LABS, INC.: 10-Q filed 2026-07-27
What GEOVAX LABS, INC. reported in its quarterly report filed 2026-07-27 (fiscal Q2 2026): 30 published measures, 79 facts as tagged in accession 0001437749-26-024523.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2026-07-27
- Fiscal period
- fiscal Q2 2026
- Accession
- 0001437749-26-024523 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GEOVAX LABS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 4,642,757 | USD | |
| At 2025-12-31 | 6,341,868 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 2,882,056 | USD | |
| At 2025-12-31 | 2,516,736 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,760,701 | USD | |
| At 2026-03-31 | 493,770 | USD | |
| At 2025-12-31 | 3,825,132 | USD | |
| At 2025-06-30 | 2,821,196 | USD | |
| At 2025-03-31 | 7,898,030 | USD | |
| At 2024-12-31 | 5,048,535 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 3,143,422 | USD | |
| At 2025-12-31 | 3,085,741 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -4,426,578 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -9,688,499 | USD | 181 |
| 2026-01-01 to 2026-03-31 | -5,261,921 | USD | 90 |
| 2025-04-01 to 2025-06-30 | -5,369,783 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -10,727,434 | USD | 181 |
| 2025-01-01 to 2025-03-31 | -5,357,651 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -7,195,824 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -10,300,078 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 0 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 27,612 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 7,253,505 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 7,914,611 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 0 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -27,612 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | -160,509,351 | USD | |
| At 2025-12-31 | -150,820,852 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 4,565,207 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 3,293,735 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 614,369 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 543,892 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -0.97 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -2.94 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -8.74 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -19.72 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 0 | USD | 91 |
| 2025-04-01 to 2025-06-30 | 0 | USD | 91 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 84,678 | USD | |
| At 2025-12-31 | 108,830 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 383,063 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 585,484 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -4,442,072 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -9,714,953 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -5,418,906 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -10,824,076 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 4,175,299 | USD | |
| At 2025-12-31 | 5,314,651 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 2,712,488 | USD | |
| At 2025-12-31 | 1,936,701 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,834,245 | USD | |
| At 2025-12-31 | 790,750 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 4,442,072 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 9,714,953 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 6,271,188 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 13,313,221 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 3,110,508 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 7,013,971 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 4,728,998 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 10,083,586 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 7,369,243 | shares | |
| At 2025-12-31 | 1,732,147 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 312,833 | USD | |
| At 2025-12-31 | 831,440 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 323,141 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 427,759 | USD | |
| At 2025-12-31 | 403,607 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 69,947 | USD | |
| At 2025-12-31 | 86,947 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 724,670 | USD | |
| At 2025-12-31 | 882,816 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,031,877 | USD | |
| At 2025-12-31 | 2,228,910 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 1,331,564 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 2,700,982 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 1,542,190 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 3,229,635 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 24,152 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 33,724 | USD | 181 |
Inspect the source
- Entity
- GEOVAX LABS, INC. / CIK 0000832489
- Captured
- 2026-09-19T15:08:35.324Z
- SEC response SHA-256
59a901b3497fda8a2be64a7de8bb7d8359e460cc8dc7a28f1eaf58764d360937
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000832489.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))